A host of sponsors and vendor companies attended the virtual AGBT General Meeting this week. Through sponsored talks and even more poster sessions, vendor companies shared their latest work and technology developments and made product announcements. “It is through genomics that we finally appear to be taking back control from the COVID pandemic and starting

DNA Script, a leading pioneer in enabling DNA on demand, shared data at this year’s Advances in Genome Biology and Technology (AGBT) General Meeting that demonstrate the comparable performance of the company’s enzymatically synthesized oligos to traditional chemically synthesized DNA in their quest to reliably support genomics and life science applications. The research, in collaboration with The Jackson

Scientific Research Community to Gain Access to First Single-Cell Spatial Genomics Turnkey System for Advancing Biomedical Research and Discovery Vizgen, the life sciences company visualizing biology to advance human health, today announced the highly anticipated MERSCOPE™ platform ahead of their presentation tomorrow at the Advances in Genome Biology and Technology (AGBT) 2021 General Meeting. Vizgen is unveiling

Data in Twenty-One Poster and Oral Presentations Highlight use of GeoMx Digital Spatial Profiler and the Spatial Molecular Imager Platform for Discovery and Translational Applications SEATTLE–(BUSINESS WIRE)– NanoString Technologies Inc.. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the launch of a Technology Access Program (TAP) for the

Today, at the Advances in Genome Biology and Technology (AGBT) 2021 General Meeting held virtually, BioSkryb, Inc., a developer of genomic amplification technologies, announced the winners of a research grant program sponsored by the company. The grant program was created to accelerate innovation of single-cell genomic studies using the primary template-directed amplification (PTA) technology developed by

Miroculus, Inc., a developer of revolutionary tools for personal lab automation today announced new research optimizing an automated PCR-free Whole Genome Sequencing (WGS) library prep workflow for very low input human samples. The work done in collaboration with the University of California San Francisco (UCSF) and Purigen Biosystems will be presented at the Advances in

ROSALIND, a leader in extracting meaningful insights from diverse pools of life science data, today announced the commercial launch of its new solution for single cell data analysis. The new analysis module, which enables web-based collaboration and the analysis and interpretation of 10X Genomics-generated single cell data, is built on the company’s proven cloud-based platform

By Elizabeth Pennisi   As with real estate, location matters greatly for cells. Douglas Strand confirmed that truth last year when he used a new technique to map gene activity in bladder cancers. Until recently, scientists wanting to know all the genes at work in a tissue could analyze single cells without knowing their position, or

Pioneering scientists at VIB, the University of Copenhagen, DKFZ, and Stanford University are the first to deploy systems that deliver the highest-resolution view of subcellular gene expression activity

Today Ultima Genomics emerged from stealth mode with a new high-throughput, low-cost sequencing platform that delivers the $100 genome. The first scientific results from leading research institutes using the platform for whole-genome sequencing, single-cell sequencing, and cancer epigenetics will be presented at AGBT in Florida next week with initial data published this week.

The AVITI System is based on a single flow cell and sequencing reagent cartridge design that offers up to 300 cycles and tunable read throughput control for each of two independently operated flow cells.

10X Genomics, Inc, a life sciences leader focused on mastering biology to advance human health, today announced a series of product updates that will be presented at the 2022 Advances in Genome Biology and Technology (AGBT) General Meeting this week in Orlando, Fla.

NanoString Technologies, Inc, a leading provider of life science tools for discovery and translational research, announced today the commercial unveiling of its new AtoMx™ Spatial Informatics Portal (SIP) at the Spatial Multiomic Symposium at the 2022 AGBT General Meeting in Orlando, FL.

Illumina, Inc, a global leader in DNA sequencing and array-based technologies, today shared key customer-focused announcements and presentations it will make at the Advances in Genome Biology and Technology (AGBT) General Meeting, taking place June 6–9 in Orlando, Fla.

The prestigious Advances in Genome Biology and Technology (AGBT) conference in Orlando Florida, Chief Scientific Officer of Cardea Bio, Dr. Kiana Aran – the 2021 winner of the Nature Research Award for Inspiring Women in Science – is a first day plenary speaker, introducing the first-generation multiomics BPUs that combine CRISPR technology with the ultra-sensitivity of a

Volta Labs is highlighting new digital fluidics technology at the Advances in Genome Biology and Technology (AGBT) General Meeting held June 6-9 in Orlando, FL.

Bio-Rad will be attending the Advances in Genome Biology and Technology (AGBT) General Meeting in Orlando, FL June 6–9, 2022. Join Bio-Rad’s speaker sessions on June 7 and 9 (Parlor Suite 709) to find out more about its novel RNA-Seq workflow or visit its poster presentations on June 8 (Posters #544 and 596).

Akoya Biosciences, Inc., The Spatial Biology Company®, will present for the first time, data generated using its proprietary RNA chemistry, which enables whole-slide spatial multiomics at single-cell resolution on the PhenoCycler-Fusion system, at the Advances in Genome Biology and Technology (AGBT) conference in Orlando, Florida, from June 6 to 9.

ZUG, Switzerland & CARLSBAD, Calif.–(BUSINESS WIRE)–Galderma, the world’s largest independent dermatology company, announced that it has signed a definitive agreement to acquire ALASTIN Skincare®, Inc. (“ALASTIN”), a specialty aesthetics company dedicated to developing innovative and clinically-tested physician-dispensed skincare products. The acquisition is subject to customary closing conditions and necessary regulatory approvals. Financial terms of the

Despite single cell RNA technologies being front and center at the AGBT meeting in Marco Island, Florida, last week, two new DNA sequencing technology presentations from MGI and Genapsys created their own buzz.

Speaking in the coveted last slot of this year’s AGBT conference*, the sequencing company MGI presented their newly developed technology and chemistry. The talk promised to be a blockbuster with the title “First $100 genome sequencing enabled by new extreme throughput DNBSEQ platform.” The MGI system can sequence genomes for the cost of $100—a highly

SAN DIEGO, Feb. 21, 2020 (GLOBE NEWSWIRE) — Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets Saphyr®, a platform for ultra-sensitive and ultra-specific structural variation detection in genome analysis, announced today that cancer, genetic disease and genomics researchers using the Saphyr system will present their results at the Advances in

With four panels covering more than 1,000 genes each, the product can get the same results for its targets as whole transcriptome profiling, with just a fifth of the number of reads per cell, 10x Staff Scientist Sarah Taylor told attendees of a lunchtime workshop sponsored by the single-cell, and now spatial, analysis company.

The Miro Canvas system is able to simplify, automate and miniaturize complex protocols such as NGS library prep, improving library consistency and eliminating the need for complex robotics. The Miroculus platform also decreases sample input requirements and reagent volumes, reducing protocol times and manual interventions, even for users of conventional lab automation.

Interest in the technology was palpable here at the Advances in Genome Biology and Technology meeting, where ReadCoor is a bronze-level sponsor. At a Monday afternoon unboxing event, more than 120 people lined up outside the corporate suite — more than could fit inside — to get the first look at the platform.

PSWICH, Mass., Feb. 21, 2020 /PRNewswire/ — This year’s Advances in Genome Biology and Technology (AGBT) General Meeting will feature scientific presentations by NEB scientists and collaborators on discoveries that address challenges across the spectrum of next generation sequencing (NGS) applications.

FARMINGTON, Conn., Feb. 21, 2020 /PRNewswire-PRWeb/ — Shoreline Biome, a microbiome research company that develops tools for characterizing microbiome populations down to the strain level, will present a poster at the 2020 Advances in Genome Biology and Technology (AGBT) General Meeting.

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the Twist Targeted Methylation Sequencing Solution to study methylation pattern changes in a wide range of research fields including cancer, epigenetics and non-invasive prenatal testing is now available for early access

Promega Corporation, a global biotechnology manufacturer, today launched its new Wizard® HMW DNA Extraction Kit for researchers working with large fragments of genomic DNA. The kit, as demonstrated in a poster presented at this week’s 2020 Advances in Genome Biology and Technology (AGBT) meeting, enables researchers to obtain DNA that will provide strong performance in long-read

NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced ten scientific studies utilizing the GeoMx™ Digital Spatial Profiler (DSP) that will be showcased at the 2020 Advances in the Genome Biology and Technology (AGBT) conference being held at the JW Marriott in Marco Island, Florida. These

A casual observer might have failed to see past the merriment—the sun and sand, the food and drink, the singing and dancing. But make no mistake, despite occurring in a resort atmosphere, the most recent Advances in Genome Biology and Technology (AGBT) meeting was mostly business.

OmicsXchange podcast, we speak with Dr. Eric Green, Director of the National Human Genome Research Institute (NHGRI), on the Advances in Genome Biology and Technology (AGBT) Precision Health Meeting. Visit agbt.org to register for the Precision Health Meeting, which takes place 8–10 September, 2022 in San Diego, USA.

In episode 18 of the GA4GH OmicsXchange podcast, we speak with Dr. Eric Green, Director of the National Human Genome Research Institute (NHGRI), on the Advances in Genome Biology and Technology (AGBT) Precision Health Meeting. Visit agbt.org to register for the Precision Health Meeting, which takes place 8–10 September 2022 in San Diego, USA.

What we discuss with Dr. Rehm: How she became interested in biology and genomics, studying the genetic basis of hearing loss, and why she thinks the cochlea is a thing of beauty, how she got involved with the Broad Institute, and her work there, some of the barriers to the use of genetics in medicine,

Advances in Genome Biology and Technology (AGBT) and the Helen Hay Whitney Foundation (HHWF) have partnered to award a new postdoctoral research fellowship that grants financial support to help further the careers of the next generation of genomics scientists engaged in biological or medical research.

To kick off the Advances in Genome Biology and Technology (AGBT) precision health meeting held in La Jolla, California early this September, David Altshuler, M.D., Ph.D., executive vice president of global research and CSO at Vertex Pharmaceuticals, shared his perspective on “humanizing drug discovery.”